ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. 2026-04-29 · Financial Post Contact Read MoreVisit newsbetting.bond for more information. Read at source